INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charter Communications, Inc. – CHTR

(NASDAQ:CHTR), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Charter Communications, Inc. (“Charter” or the “Company”) (NASDAQ: CHTR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Charter and certain of its officers and/or directors have […]

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Molina Healthcare, Inc. – MOH

(NYSE:MOH), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Molina and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. – ANIK

(NASDAQ:ANIK), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ: ANIK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Anika and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S – NVO

(NYSE:NVO), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Novo Nordisk A/S (“Novo Nordisk” or the “Company”) (NYSE: NVO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Novo Nordisk and certain of its officers and/or

Soliant Health Crowns ‘America’s Most Beautiful Hospital’ Contest Winners

ATLANTA, GA., Aug. 01, 2025 (GLOBE NEWSWIRE) — Soliant Health, a top healthcare and education staffing provider, is proud to announce the winners of its 2025 Most Beautiful Hospitals contest. After earning a remarkable 1,067,862 votes from hospital staff, patients, and community members, Chickasaw Nation Medical Center (CNMC) in Ada, OK, has been officially named

Bill Savings Advocate Announces Cost-Neutral Employee Benefits Program Powered By FICA Tax Credit

Harlan, IA , Aug. 01, 2025 (GLOBE NEWSWIRE) — Bill Savings Advocate, a national provider of results-paid expense reduction solutions, today announced the launch of a groundbreaking employee benefits program that delivers comprehensive healthcare, mental health, free pharmacy, and wellness services–at zero out-of-pocket cost to employees and no added cost to employers. Funded through the

Video Explores How Elon Musk’s Starlink Could Reshape Everyday Life Ahead of Predicted August 13 Announcement

Baltimore, MD, Aug. 01, 2025 (GLOBE NEWSWIRE) — A released briefing featuring entrepreneur James Altucher examines the human impact of Elon Musk's Starlink technology and how it could permanently alter communications, commerce, and access to information worldwide. “This innovation could dramatically change our way of living — and even America's future — forever, over the

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. – EWTX

(NASDAQ:EWTX), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. (“Edgewise” or the “Company”) (NASDAQ: EWTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Edgewise and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Groupon, Inc. – GRPN

(NASDAQ:GRPN), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Groupon, Inc. (“Groupon” or the “Company”) (NASDAQ: GRPN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Groupon and certain of its officers and/or directors have engaged

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. – ALT

(NasdaqGM:ALT), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Altimmune and certain of its officers and/or directors have engaged

Scroll to Top